These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20683172)

  • 41. Subclinical hyperthyroidism and sport eligibility: an exploratory study on cardiovascular pre-participation screening in subjects treated with levothyroxine for multinodular goiter.
    Di Luigi L; Parisi A; Quaranta F; Romanelli F; Tranchita E; Sgrò P; Nardi P; Fattorini G; Cavaliere R; Pigozzi F; D'Armiento M; Lenzi A
    J Endocrinol Invest; 2009 Nov; 32(10):825-31. PubMed ID: 19609103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The LISA trial-a- randomized, double-blind, placebo-controlled four-arm study of 1,000 patients with nodular goiter in Germany. Study Design and first results of feasibility].
    Grussendorf M; Vaupel R; Reiners C; Wegscheider K;
    Med Klin (Munich); 2005 Sep; 100(9):542-6. PubMed ID: 16170642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of percutaneous ethanol injections in benign thyroid nodules.
    Perez CL; Fighera TM; Miasaki F; Mesa Junior CO; Paz Filho GJ; Graf H; Carvalho GA
    Arq Bras Endocrinol Metabol; 2014 Dec; 58(9):912-7. PubMed ID: 25627046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation and management of multinodular goiter.
    Hurley DL; Gharib H
    Otolaryngol Clin North Am; 1996 Aug; 29(4):527-40. PubMed ID: 8844728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
    Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group.
    Wémeau JL; Caron P; Schvartz C; Schlienger JL; Orgiazzi J; Cousty C; Vlaeminck-Guillem V
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4928-34. PubMed ID: 12414852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Levothyroxine treatment in pediatric benign thyroid nodules.
    Corrias A; Mussa A; Wasniewska M; Segni M; Cassio A; Salerno M; Gastaldi R; Vigone MC; Bal M; Matarazzo P; Weber G; De Luca F
    Horm Res Paediatr; 2011; 75(4):246-51. PubMed ID: 21135537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Three cases of multinodular toxic goiter (author's transl)].
    Ishii H; Mori T; Takayama H; Konishi J; Kasagi K; Endo K; Torizuka K
    Nihon Naibunpi Gakkai Zasshi; 1978 Dec; 54(12):1399-406. PubMed ID: 581866
    [No Abstract]   [Full Text] [Related]  

  • 49. Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial.
    Nielsen VE; Bonnema SJ; Hegedüs L
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1317-22. PubMed ID: 16434453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyroid morphology and function after surgical treatment of thyroid diseases.
    Mann B; Schmale P; Stremmel W
    Exp Clin Endocrinol Diabetes; 1996; 104(3):271-7. PubMed ID: 8817246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of Metformin treatment in obese insulin-resistant patients with euthyroid goiter.
    Răcătăianu N; Bolboacă SD; Sitar-Tăut AV; Mârza S; Moga D; Valea A; Ghervan C
    Acta Clin Belg; 2018 Oct; 73(5):317-323. PubMed ID: 29452573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
    Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB
    Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes in both size and cytological features of thyroid nodule after levothyroxine treatment.
    Vermiglio F; Lo Presti VP; Violi MA; Moleti M; Castagna MG; Finocchiaro MD; Mattina F; Mandolfino M; Zimbaro G; Trimarchi F
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):347-53. PubMed ID: 12919158
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Levothyroxine treatment of the solitary thyroid nodule].
    Almodóvar Ruiz F; Maldonado Castro G; de Luis D; Lahera M; Varela da Costa C
    An Med Interna; 2000 Feb; 17(2):99-101. PubMed ID: 10829467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-energy interstitial laser photocoagulation for treatment of nonfunctioning thyroid nodules: therapeutic outcome in relation to pretreatment and treatment parameters.
    Amabile G; Rotondi M; De Chiara G; Silvestri A; Di Filippo B; Bellastella A; Chiovato L
    Thyroid; 2006 Aug; 16(8):749-55. PubMed ID: 16910876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Goiter and nodular thyroid disease: clinical guidelines for diagnosis and treatment. (Waiting? Hormone therapy? Surgery? radioiodine?)].
    Cattaneo F; Bürgi U; Mueller B
    Ther Umsch; 1999 Jul; 56(7):356-63. PubMed ID: 10434771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective, randomized, double-blind study about effectiveness of levothyroxine suppressive therapy in prevention of recurrence after operation: result at the third year of follow-up.
    Miccoli P; Antonelli A; Iacconi P; Alberti B; Gambuzza C; Baschieri L
    Surgery; 1993 Dec; 114(6):1097-101; discussion 1101-2. PubMed ID: 8256213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. The Multicenter Study Group.
    Lippi F; Ferrari C; Manetti L; Rago T; Santini F; Monzani F; Bellitti P; Papini E; Busnardo B; Angelini F; Pinchera A
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3261-4. PubMed ID: 8784080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of suppressive thyroxine therapy in nodular goiter in postmenopausal women and 2 year's bone mineral density change.
    Chen CY; Chen ST; Huang BY; Hwang JS; Lin JD; Liu FH
    Endocr J; 2018 Nov; 65(11):1101-1109. PubMed ID: 30158361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The effect of levothyroxine suppression therapy for benign thyroid nodules on bone metabolism in premenopausal women].
    Akinci B; Demir T; Cömlekçi A; Karaoğlu O; Seçil M; Yeşil S
    Kulak Burun Bogaz Ihtis Derg; 2008; 18(4):232-7. PubMed ID: 19052491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.